New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Prime Medicine, Inc.
PRME
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

498M

Biotechnology

Next Earning date - 01 Nov 2024

498M

Biotechnology

Next Earning date - 01 Nov 2024

4.15USD
Shape0.12 ( 2.98%)
Market Open
favorite-chart

Relative Strenght

10
favorite-chart

Volume Buzz

-76%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

58%

Quote Panel

Shape
Updated October 28, 2024
1W -7.17 % 1M 6.98 % 3M -25.67 % 1Y -28.87 %

Key Metrics

Shape
  • Market Cap

    498.13M


  • Shares Outstanding

    120.03M


  • Share in Float

    39.57M


  • Dividende

    0


  • Earning Date

    01 Nov 2024


  • Price Target

    4.15


  • Average Volume

    1.40M


  • Beta

    2.183


  • Range

    3.28-9.86


  • Industry

    Biotechnology


  • Website

    https://www.primemedicine.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

12.48x

P/S Ratio

2.52x

P/B Ratio

0.2

Debt/Equity

-544.9%

Net Margin

$-2.2

EPS

How PRME compares to sector?

P/E Ratio

Relative Strength

Shape

PRME

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$6M

Shape-86%

2025-Revenue

$1.37

Shape-197%

2025-EPS

$3M

Shape106%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

H.C. Wainwright

initialise

Previous: Not converted

2024-05-20

Now: Buy

Citigroup

upgrade

Previous: Not converted

2024-05-15

Now: Buy

Cowen & Co.

initialise

Previous: Not converted

2024-04-08

Now: Buy

Wedbush

initialise

Previous: Buy

2024-04-03

Now: Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.31
vs -0.23

Q4.22

arrow
arrow

N/A

-0.56
vs -0.88

Q1.23

arrow
arrow

N/A

-0.44
vs -0.33

Q2.23

arrow
arrow

N/A

-0.47
vs -0.41

Q3.23

arrow
arrow

N/A

-0.55
vs -0.31

Q4.23

arrow
arrow

N/A

-0.56
vs -0.56

Q1.24

arrow
arrow

N/A

-0.44
vs -0.44

Q2.24

arrow
arrow

N/A

-0.46
vs -0.47

Q3.24

arrow
arrow

N/A

-0.39
vs -0.55

Q4.24

arrow
arrow

N/A

-0.38
vs -0.56

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

NA  vs NA

Q1.24

arrow
arrow

NA

591K  vs NA

Q2.24

arrow
arrow

NA

39.3M  vs NA

Q3.24

arrow
arrow

NA

7.1M  vs NA

Q4.24

arrow
arrow

NA

6.6M  vs NA

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-21%

-0.21
vs -0.18

Q4.22

arrow
arrow

+13%

0.13
vs -0.21

Q1.23

arrow
arrow

-14%

-0.14
vs 0.13

Q2.23

arrow
arrow

-18%

-0.18
vs -0.14

Q3.23

arrow
arrow

-26%

-0.26
vs -0.18

Q4.23

arrow
arrow

-49%

-0.49
vs -0.26

Q1.24

arrow
arrow

-19%

-0.19
vs -0.49

Q2.24

arrow
arrow

-28%

-0.28
vs -0.19

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News